- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 28-05-2026: Press Release
28-05-2026 | 09:18 am
28-05-2026 | 09:18 am
Wockhardt secures Indian market authorization for its breakthrough antibiotic, ZAYNICH®, treating complicated urinary tract infections. This first-in-class drug demonstrated superior efficacy in trials, targeting critical resistant infections.
No comments yet. Be the first to comment!